ATE279948T1 - Gas und destabilisierungsmittel enthaltende ultraschallkontrastmitteldispersonen - Google Patents

Gas und destabilisierungsmittel enthaltende ultraschallkontrastmitteldispersonen

Info

Publication number
ATE279948T1
ATE279948T1 AT99918140T AT99918140T ATE279948T1 AT E279948 T1 ATE279948 T1 AT E279948T1 AT 99918140 T AT99918140 T AT 99918140T AT 99918140 T AT99918140 T AT 99918140T AT E279948 T1 ATE279948 T1 AT E279948T1
Authority
AT
Austria
Prior art keywords
agent
gas
preparations
perfusion
dispersons
Prior art date
Application number
AT99918140T
Other languages
English (en)
Inventor
Roald Skurtveit
Olaug Hjelstuen
Jonny Ostensen
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Health As filed Critical Amersham Health As
Application granted granted Critical
Publication of ATE279948T1 publication Critical patent/ATE279948T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99918140T 1998-04-22 1999-04-22 Gas und destabilisierungsmittel enthaltende ultraschallkontrastmitteldispersonen ATE279948T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9808582.2A GB9808582D0 (en) 1998-04-22 1998-04-22 Improvements in or relating to contrast agents
PCT/GB1999/001228 WO1999053964A1 (en) 1998-04-22 1999-04-22 Ultrasound contrast agent dispersions comprising gas and destabilising agent

Publications (1)

Publication Number Publication Date
ATE279948T1 true ATE279948T1 (de) 2004-11-15

Family

ID=10830791

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99918140T ATE279948T1 (de) 1998-04-22 1999-04-22 Gas und destabilisierungsmittel enthaltende ultraschallkontrastmitteldispersonen

Country Status (7)

Country Link
EP (1) EP1079865B1 (de)
JP (1) JP2002512207A (de)
AT (1) ATE279948T1 (de)
AU (1) AU3617499A (de)
DE (1) DE69921317T2 (de)
GB (1) GB9808582D0 (de)
WO (1) WO1999053964A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804162A (en) * 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
US6962071B2 (en) * 2001-04-06 2005-11-08 Bracco Research S.A. Method for improved measurement of local physical parameters in a fluid-filled cavity
JP2013180956A (ja) * 2012-02-29 2013-09-12 Sunstar Engineering Inc 殺菌剤組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3834705A1 (de) * 1988-10-07 1990-04-12 Schering Ag Ultraschallkontrastmittel aus gasblaeschen und fettsaeure enthaltenden mikropartikeln
DE3529195A1 (de) * 1985-08-14 1987-02-26 Max Planck Gesellschaft Kontrastmittel fuer ultraschalluntersuchungen und verfahren zu seiner herstellung
AU7655194A (en) * 1993-09-09 1995-03-27 Schering Aktiengesellschaft Active principles and gas containing microparticles
US5560364A (en) * 1995-05-12 1996-10-01 The Board Of Regents Of The University Of Nebraska Suspended ultra-sound induced microbubble cavitation imaging
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
JP2001502349A (ja) * 1996-10-21 2001-02-20 ニユコメド・イメージング・アクシエセルカペト 造影剤におけるまたはこれに関する改良

Also Published As

Publication number Publication date
JP2002512207A (ja) 2002-04-23
DE69921317T2 (de) 2005-11-10
DE69921317D1 (de) 2004-11-25
GB9808582D0 (en) 1998-06-24
EP1079865B1 (de) 2004-10-20
AU3617499A (en) 1999-11-08
EP1079865A1 (de) 2001-03-07
WO1999053964A1 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
NZ335265A (en) Gas containing contrast agents that may be co-administered with vasodilator drugs to enhance differences in return signal intensity from normal and hypoperfused myocardial tissue contrast agents
GB9808599D0 (en) Improvements in or realting to contrast agents
DE59908745D1 (de) Pharmazeutische ciclosporin-formulierung mit verbesserten biopharmazeutischen eigenschaften, erhöhter physikalischer qualität & stabilität sowie verfahren zur herstellung
RU94033520A (ru) Впрыскиваемый лецитиновый гель
AR032073A1 (es) Las nanoparticulas lipidas anfifilicas para la incorporacion de los peptidos y/o las proteinas
EA200400242A1 (ru) Фармацевтические композиции, содержащие бета-лапахон или его производные или аналоги, и способы их применения
SE8705043L (sv) Hydrosoler av farmakologiskt aktiva medel samt farmaceutiska kompositioner innefattande dessa
ATE72629T1 (de) Cyclosporin enthaltende pharmazeutische zubereitung.
DE69105106D1 (de) Im wasser schnell suspendierbare pharmazeutische zusammensetzung.
BR9714015A (pt) Formulações farmacêuticas para distribuição de droga prolongada
ATE268605T1 (de) Pharmazeutische akzeptabel dnase zusammensetzung
RU99115103A (ru) Фармацевтическая композиция для задержанной доставки пептидного соединения (варианты) и ее применение, упакованный препарат для лечения состояния, поддающегося воздействию аналога lhrh, шприц
BR9610059A (pt) Método para detectar doença pulmomar
EA200100828A1 (ru) 16-гидроксиэстратриены в качестве эстрогенов избирательного действия
ATE279948T1 (de) Gas und destabilisierungsmittel enthaltende ultraschallkontrastmitteldispersonen
RU96120655A (ru) Композиция для профилактики и лечения гриппа и орви
ATE230251T1 (de) Lipidmembran zusammensetzungen
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
NO20004816L (no) Ny farmasøytisk formulering
KR900017599A (ko) 종양 치료용 약학 조성물
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
GR890100737A (el) Μέ?οδος παρασκευής μιας φαρμακευτικής συν?έσεως δι'οφ?αλμική χρήσιν η οποία περιλαμβάνει ένα υδατοδιαλυτό άλας δια προσ?ήκης οξέος ιμποπαμίνης.
BR0109525A (pt) Composição, uso de uma composição, tabletes ou cápsulas, e, método de preparação de uma solução ou suspensão
Kogure et al. The delivery of protein into living cells by use of membrane fusible erythrocyte ghosts
Korbin et al. Antiarrhythmic effect of estradiol-dipropionate in animals of different sexes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties